The Company is developing Teverelix® as a best-in-class market product for advanced prostate cancer patients with high CV ...
The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...
The Casppian study design included periodic evaluations and long-term safety monitoring for up to a total of 12 months following the first injection. -- There has been no safety concern with the use ...
Foresee Pharma gets fourth positive recommendation from DSMB to continue the Casppian Ph3 study, for central precocious puberty: Taipei Friday, February 6, 2026, 18:00 Hrs [IST] F ...
Veru Inc. (NASDAQ:VERU) Q1 2026 Earnings Call Transcript February 11, 2026 Veru Inc. beats earnings expectations. Reported EPS is $-0.26254, expectations were $-0.47. Operator: Good morning, ladies ...
Under its former childhood vaccine schedule, the U.S. Centers for Disease Control and Prevention recommended that kids get 12 different vaccines protecting against 16 diseases before age 10. It didn’t ...
The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...
Methotrexate injection, a treatment for certain autoimmune diseases and cancers, can lead to various side effects. These range from common, mild reactions such as headache and nausea to serious, ...
It’s hard to think of vaccination without associating it with a sharp jab in the arm. But there are other, more gentle ways of activating the immune system, such as administering vaccines via the nose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results